CRNX logo

CRNX Depreciation & Amortization

Annual D&A:

$2.79M+$1.69M(+153.64%)
December 31, 2024

Summary

  • As of today, CRNX annual D&A is $2.79 million, with the most recent change of +$1.69 million (+153.64%) on December 31, 2024.
  • During the last 3 years, CRNX annual D&A has risen by +$1.86 million (+202.06%).
  • CRNX annual D&A is now at all-time high.

Performance

CRNX Depreciation & Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRNXincome statement metrics

Quarterly D&A:

$1.01M+$53.00K(+5.53%)
September 30, 2025

Summary

  • As of today, CRNX quarterly D&A is $1.01 million, with the most recent change of +$53.00 thousand (+5.53%) on September 30, 2025.
  • Over the past year, CRNX quarterly D&A has increased by +$242.00 thousand (+31.43%).
  • CRNX quarterly D&A is now at all-time high.

Performance

CRNX Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRNXincome statement metrics

TTM D&A:

$3.68M+$242.00K(+7.03%)
September 30, 2025

Summary

  • As of today, CRNX TTM D&A is $3.68 million, with the most recent change of +$242.00 thousand (+7.03%) on September 30, 2025.
  • Over the past year, CRNX TTM D&A has increased by +$1.43 million (+63.08%).
  • CRNX TTM D&A is now at all-time high.

Performance

CRNX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRNXincome statement metrics

CRNX Depreciation & Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+153.6%+31.4%+63.1%
3Y3 Years+202.1%+188.3%+177.6%
5Y5 Years+214.0%+221.3%+166.6%

CRNX Depreciation & Amortization Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+202.1%at high+2430.0%at high+235.5%
5Y5-Yearat high+214.0%at high+2430.0%at high+235.5%
All-TimeAll-Timeat high+2927.2%at high+3648.2%at high>+9999.0%

CRNX Depreciation & Amortization History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.01M(+5.5%)
$3.68M(+7.0%)
Jun 2025
-
$959.00K(+3.7%)
$3.44M(+6.4%)
Mar 2025
-
$925.00K(+17.4%)
$3.24M(+16.2%)
Dec 2024
$2.79M(+153.6%)
$788.00K(+2.3%)
$2.79M(+23.3%)
Sep 2024
-
$770.00K(+2.3%)
$2.26M(+47.7%)
Jun 2024
-
$753.00K(+58.9%)
$1.53M(+30.2%)
Mar 2024
-
$474.00K(+80.9%)
$1.17M(+6.9%)
Dec 2023
$1.10M(+11.7%)
$262.00K(+555.0%)
$1.10M(-10.3%)
Sep 2023
-
$40.00K(-89.9%)
$1.22M(-20.3%)
Jun 2023
-
$398.00K(0.0%)
$1.53M(+5.7%)
Mar 2023
-
$398.00K(+2.6%)
$1.45M(+4.5%)
Dec 2022
$983.00K(+6.6%)
$388.00K(+10.5%)
$1.39M(+4.7%)
Sep 2022
-
$351.00K(+11.4%)
$1.33M(+2.5%)
Jun 2022
-
$315.00K(-6.0%)
$1.29M(+0.2%)
Mar 2022
-
$335.00K(+2.8%)
$1.29M(+2.5%)
Dec 2021
$922.00K
$326.00K(+2.2%)
$1.26M(+2.2%)
Sep 2021
-
$319.00K(+1.9%)
$1.24M(+0.3%)
DateAnnualQuarterlyTTM
Jun 2021
-
$313.00K(+3.0%)
$1.23M(+0.1%)
Mar 2021
-
$304.00K(+1.7%)
$1.23M(+0.3%)
Dec 2020
$948.00K(+6.9%)
$299.00K(-5.1%)
$1.23M(-11.3%)
Sep 2020
-
$315.00K(+1.0%)
$1.38M(+6.7%)
Jun 2020
-
$312.00K(+4.0%)
$1.29M(+11.6%)
Mar 2020
-
$300.00K(-34.1%)
$1.16M(+4.2%)
Dec 2019
$887.00K(+88.3%)
$455.00K(+99.6%)
$1.11M(+28.5%)
Sep 2019
-
$228.00K(+28.8%)
$866.00K(+11.5%)
Jun 2019
-
$177.00K(-30.0%)
$777.00K(+14.9%)
Mar 2019
-
$253.00K(+21.6%)
$676.00K(+43.5%)
Dec 2018
$471.00K(+268.0%)
$208.00K(+49.6%)
$471.00K(+51.4%)
Sep 2018
-
$139.00K(+82.9%)
$311.00K(+55.5%)
Jun 2018
-
$76.00K(+58.3%)
$200.00K(+61.3%)
Mar 2018
-
$48.00K(0.0%)
$124.00K(+20.4%)
Dec 2017
$128.00K(+39.1%)
$48.00K(+71.4%)
$103.00K(+87.3%)
Sep 2017
-
$28.00K(+3.7%)
$55.00K(+103.7%)
Mar 2017
-
$27.00K
$27.00K
Dec 2016
$92.00K
-
-

FAQ

  • What is Crinetics Pharmaceuticals, Inc. annual D&A?
  • What is the all-time high annual D&A for Crinetics Pharmaceuticals, Inc.?
  • What is Crinetics Pharmaceuticals, Inc. annual D&A year-on-year change?
  • What is Crinetics Pharmaceuticals, Inc. quarterly D&A?
  • What is the all-time high quarterly D&A for Crinetics Pharmaceuticals, Inc.?
  • What is Crinetics Pharmaceuticals, Inc. quarterly D&A year-on-year change?
  • What is Crinetics Pharmaceuticals, Inc. TTM D&A?
  • What is the all-time high TTM D&A for Crinetics Pharmaceuticals, Inc.?
  • What is Crinetics Pharmaceuticals, Inc. TTM D&A year-on-year change?

What is Crinetics Pharmaceuticals, Inc. annual D&A?

The current annual D&A of CRNX is $2.79M

What is the all-time high annual D&A for Crinetics Pharmaceuticals, Inc.?

Crinetics Pharmaceuticals, Inc. all-time high annual D&A is $2.79M

What is Crinetics Pharmaceuticals, Inc. annual D&A year-on-year change?

Over the past year, CRNX annual D&A has changed by +$1.69M (+153.64%)

What is Crinetics Pharmaceuticals, Inc. quarterly D&A?

The current quarterly D&A of CRNX is $1.01M

What is the all-time high quarterly D&A for Crinetics Pharmaceuticals, Inc.?

Crinetics Pharmaceuticals, Inc. all-time high quarterly D&A is $1.01M

What is Crinetics Pharmaceuticals, Inc. quarterly D&A year-on-year change?

Over the past year, CRNX quarterly D&A has changed by +$242.00K (+31.43%)

What is Crinetics Pharmaceuticals, Inc. TTM D&A?

The current TTM D&A of CRNX is $3.68M

What is the all-time high TTM D&A for Crinetics Pharmaceuticals, Inc.?

Crinetics Pharmaceuticals, Inc. all-time high TTM D&A is $3.68M

What is Crinetics Pharmaceuticals, Inc. TTM D&A year-on-year change?

Over the past year, CRNX TTM D&A has changed by +$1.43M (+63.08%)
On this page